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Purpose: To evaluate the characteristic ultrasonographic (US) features of metastatic carcinoma 
to the thyroid, and how accurate US features and ultrasonography-guided fine-needle aspiration 
(US-FNA) are for the diagnosis of thyroid metastases.
Methods: Twenty-three thyroid lesions in 23 patients (mean age, 66.7 years; range, 46 to 
85 years) that had been diagnosed as thyroid metastases were included. The composition, 
echogenicity, margin, shape, presence of calcifications, underlying parenchymal echotexture, 
and vascularity were analyzed in US images of the thyroid metastases. Final US assessments 
were categorized into probably benign and suspicious malignancy. The presence of suspicious 
metastatic cervical lymph nodes was noted. The medical records, US-FNA cytology, and pathology 
reports of these patients were retrospectively reviewed.
Results: Of the 23 thyroid lesions, the general US appearance was mass-forming in 21 (91.3%) 
and non-mass-forming in 2 (8.7%). All 23 lesions showed a solid tumor composition. Common 
US features among the 21 mass-forming thyroid metastases were hypoechogenicity (81.0%), 
non-circumscribed margins (90.5%), no calcifications (76.2%), and parallel shape (81.0%). 
Suspicious cervical lymph nodes were present in 18 patients (78.3%). Of the 23 lesions, 21 
(91.3%) were classified as suspicious malignancy, and 2 (8.7%) as probably benign. US-FNA 
showed diagnostic results specific for metastases in 21 of the 22 patients (95.5%) who had 
undergone US-FNA. 
Conclusion: Common US features in thyroid metastasis were hypoechogenicity, non-
circumscribed margins, no calcifications, parallel shape, and the presence of suspicious cervical 
lymph nodes. US-FNA can be effectively used in the diagnosis of thyroid metastasis, preventing 
unnecessary surgery.
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ORIGINAL ARTICLE
Introduction
With the exponential development of diagnostic and therapeutic technology, the overall survival 
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of patients who have been diagnosed with a specific neoplasm 
has increased. Along with prolonged patient survival, detection of 
secondary involvement of the malignant neoplasm in other organs, 
that is, distant metastases, has also increased [1,2]. Detection and 
diagnosis of distant metastases has critical significance, since this 
directly affects the prognosis and treatment planning. 
Theoretically, distant metastasis can involve any organ of the 
body, including the thyroid gland. Metastasis to the thyroid gland 
is rarely observed in clinical practice, but overall incidences have 
been reported to range from 1.9% to 24% in various autopsy 
series [3-5], with metastasis from the kidney, breast, and lungs 
most frequently reported [4,6,7]. Asymptomatic thyroid nodules 
are nowadays commonly found due to widespread ultrasonography 
(US) examinations, and when considering the clinical significance of 
metastatic carcinoma to the thyroid in cancer patients, differential 
diagnosis between primary thyroid disease and metastatic ones is 
essential. US is a safe, easy, and accurate imaging modality that 
shows excellent performance when used in imaging of the thyroid 
and adjacent neck areas, and it enables US-guided fine-needle 
aspiration (US-FNA), which is considered the gold standard in the 
preoperative diagnosis of various thyroid lesions [8-10]. Although 
reported in fragments in studies on the clinical characteristics and 
prognosis of thyroid metastases [3,4,11,12], to our knowledge 
only a few studies have reported in general on the US features of 
metastatic carcinoma of the thyroid [13-15]. The purpose of this 
study was to evaluate the characteristic US features of metastatic 
carcinoma of the thyroid, and how accurate these imaging features 
and cytology results obtained from US-FNA are in the diagnosis of 
metastases to the thyroid gland.
Materials and Methods
Patients
This retrospective study was approved by our Institutional Review 
Board (IRB) and neither patient approval nor informed consent was 
required for the review of medical records or US images. Informed 
consent was signed and obtained from all patients prior to US-FNA 
or surgery. 
From January 2003 to December 2009, we searched the medical 
records database of our institution for the diagnosis of ‘thyroid 
metastases.’ During this period, 27 patients were diagnosed with 
metastatic lesions to the thyroid gland by US-FNA, US-guided core 
needle biopsy (US-CNB) or surgery. Among them, 3 were excluded 
for the following reasons: metastasis originating from direct invasion 
of the primary mass located near the thyroid such as the thymus 
and esophagus (n=2) or failure to obtain US images (n=1). One 
case that had been published in a previous report was also excluded 
[16]. A total of 23 thyroid nodules in 23 patients were included in 
this study. The medical records, US images and radiological reports, 
and cytopathologic reports of these patients were retrospectively 
reviewed.
US Imaging and US-FNA Procedures 
US was performed in all patients using a 7- to 15-MHz linear array 
transducer (HDI 3000 or 5000; Philips Medical Systems, Bothell, 
WA, USA) or a 5- to 12-MHz linear array transducer (iU22; Philips 
Medical Systems). Compound imaging was obtained in all images 
using HDI5000 or iU22 machines.
Real-time US was performed by 1 of 5 board-certified radiologists 
with 1-15 years of experience in thyroid imaging. To reduce the 
interobserver  variability of the US features of the thyroid masses, 
the US images were retrospectively reviewed by 1 radiologist (JHY) 
with 4 years of experience in thyroid imaging. This radiologist was 
informed of the presence of metastatic carcinoma to the thyroid in 
the patients during image review. The general US appearance of the 
lesions diagnosed as thyroid metastasis was categorized as follows: 
mass-forming, for lesions that showed obvious borders between 
the metastatic lesion and surrounding thyroid parenchyma, and 
non-mass-forming, for lesions that did not show clear-cut borders 
between the metastatic lesion and thyroid parenchyma. 
The US features of the mass-forming metastatic lesions were 
classified into the following categories: internal component (solid, 
mixed solid and cystic, or cystic), echogenicity (hyper- or isoechoic, 
hypoechoic compared to the thyroid parenchyma, or markedly 
hypoechoic compared to the strap muscle), margin (circumscribed, 
microlobulated, or irregular), presence of calcifications, and shape 
(parallel, defined as being greater in its transverse dimension 
than the anteroposterior dimension; or non-parallel, defined as 
being greater in its anteroposterior dimension than the transverse 
dimension) [17]. Malignant US features were defined as marked 
hypoechogenicity, non-circumscribed margins, presence of 
calcifications, and non-parallel shape, based on previously published 
criteria [17]. Final assessments of the thyroid nodules were given 
as ‘probably benign’ when none of the suspicious US features 
described above were present or ‘suspicious malignancy’ when 
1 or more suspicious US features described above were present. 
Vascularity measured on power Doppler US was available in 16 
patients, and was categorized into no, peripheral, or intranodular 
vascularity [18].
The extent of the metastatic lesion to the thyroid was classified 
into one of three categories: single; multifocal, defined as multiple 
lesions showing similar US features to the biopsy-proven index 
mass involving one thyroid lobe; or bilateral, defined as multiple 
suspicious masses similar to the index mass involving both thyroid Jung Hyun Yoon, et al.
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lobes [5]. The cervical areas were thoroughly evaluated during US for 
the presence of metastatic lymph nodes, and lymph nodes showing 
1 or more of the following US features were considered suspicious: 
loss of fatty hilum, cystic change, round shape (long/transverse 
diameter ratio <1.5), or mixed and peripheral vascular pattern on 
power Doppler [19,20]. 
US-FNA and Cytological Analyses
US-FNA or US-CNB was subsequently performed by the same 
radiologist who obtained the real-time US images. In cases of 
patients with multiple lesions, US-FNA or biopsy was performed 
targeting the lesion with the most suspicious US feature, or at the 
largest mass when multiple lesions showed similar US features. US-
FNA was performed with a range of 2 to 4 passes from the targeted 
thyroid nodule using a 23-gauge needle attached to a 20-mL 
disposable syringe with an aspirator or a 23-gauge needle attached 
to a 2-mL disposable syringe without an aspirator, depending on 
the radiologist’s preference. US-CNB was performed in 3 patients 
for more confirmative pathology results after ambiguous cytology 
results (n=1), and for additional immunohistochemistry staining 
for differential diagnosis after being diagnosed with metastasis on 
cytology (n=2). Using an 18-gauge automated core biopsy needle 
and a spring-loaded biopsy gun (Promac 2.2L; Manan Medical 
Products, Northbrook, IL, USA), two cores were routinely obtained 
from each patient. Local anesthesia was not routinely applied during 
US-FNA but was used during US-CNB. Aspirated material from US-
FNA was expelled onto glass slides, smeared, and immediately 
placed in 95% alcohol for Papanicolaou staining. The remaining 
material in the syringe was rinsed in normal saline for cell block 
processing. 
Table 1. Clinicopathologic features of the 23 patients with thyroid metastases
No. Gender/
age
Primary cancer 
site
Detection
Primary tumor 
diagnosis to thyroid 
metastases (mo)
Metastasis 
to other 
sites
Treatment Survival 
(mo)
Diagnostic method Surgery
1 M/66 Lung PE Synchronous - Chemotherapy 13 US-FNA -
2 F/52 Breast PE 24  Bone - 2 US-FNA -
3 M/77 Oropharynx PET 121 Lung Chemotherapy 8 US-FNA
Right 
lobectomy
4 F/70 Colon PET Synchronous
Liver, lung, 
bone - 3 US-FNA -
5 F/51 Breast US 134 Liver, bone Chemotherapy 4 US-FNA -
6 M/78 Glottis PET Synchronous - Chemotherapy 38 US-FNA -
7 F/72 Lung PE 119 - Chemotherapy 46, Alive US-FNA -
8 F/76 Lung PE Synchronous Bone Chemotherapy 31 US-FNA -
9 F/51 Uterine cervix PE 11 Lung, brain Chemotherapy 2 US-FNA, US-CNB -
10 F/78 Lung PET 6 Lung Chemotherapy 7 US-FNA -
11 M/46 Stomach PE 16 Liver Chemotherapy 19 US-FNA -
12 M/67 Colon PET 93 Lung Chemotherapy 12 US-FNA Total 
thyroidectomy
13 F/50 Breast PET 24 Lung Chemotherapy 5 US-FNA -
14 F/62 Lung PET Synchronous - Chemotherapy 60, Aalive US-FNA -
15 M/59 Primary unknown PE Synchronous Liver - 2 US-FNA,  US-CNB -
16 F/81 Primary unknown PET Synchronous Lung Chemotherapy 3 US-FNA -
17 M/67 Lung CT Synchronous Liver - 2 US-FNA -
18 M/78 Kidney PET 192 Lung Chemotherapy 29 US-FNA, US-CNB -
19 M/85 Colon PE 23 - Chemotherapy 2 US-CNB -
20 M/73 Lung PET 11 - - 3 US-FNA -
21 M/76 Lung PET 43 - - 3 US-FNA -
22 M/61 Gallbladder CT Synchronous Bone - 6 US-FNA -
23 M/57 Lung CT Synchronous - - 6 US-FNA -
PE, physical examination; PET, 18F-fluorodeoxyglucose (FDG) positron emission tomography; CT, computed tomography; US-FNA, ultrasonography-guided fine needle 
aspiration; US-CNB, ultrasonography-guided core needle biopsy.Metastases to the thyroid gland
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One of 5 cytopathologists specializing in thyroid pathology 
interpreted the slides or specimen obtained from US-FNA or US-
CNB, respectively. The cytopathologists were not present during 
biopsy procedures, and additional staining was performed on a 
case-by-case basis at the suggestion of the cytopathologist. 
Results
Clinical Features of the Patients
The clinical features of the 23 patients are summarized in Table 1. 
Of the 23 patients included in this study, 13 (56.5%) were men 
and 10 (43.5%) were women. The mean age of the patients at the 
time of diagnosis of thyroid metastasis was 66.7 years (range, 46 
to 85 years). Metastatic lesions to the thyroid were detected by 
the presence of symptoms or abnormal features during physical 
examination (n=8), or incidentally by various imaging modalities 
such as US, computed tomography (CT), or positron emission 
tomography (PET; n=15). 
The locations of the primary tumor in the 23 patients with 
thyroid metastasis were as follows: lung (n=9), colon (n=3), breast 
(n=3), head and neck (n=2), uterine cervix (n=1), stomach (n=1), 
gallbladder (n=1), kidney (n=1), and primary unknown (n=2). 
Fourteen patients (60.9%) had metastatic lesions in organs other 
than the thyroid, such as the liver, lungs, bone, and brain. Thyroid 
metastasis was detected during initial diagnosis and routine work-
up for cancer staging of the primary tumor in 10 patients. The mean 
interval between the primary tumor diagnosis and thyroid metastasis 
of the remaining 13 patients was 62.8 months, ranging from 6 to 
192 months. 
Two of the patients had lobectomy performed simultaneously to 
the operation on the primary tumor, of which both were confirmed 
to have metastatic thyroid carcinoma by surgical pathology. Fifteen 
patients were treated with chemotherapy, while the remaining 8 
patients were referred to hospice care. Twenty-one patients have 
expired and 2 are alive to the present date, having survived for 
46 and 60 months, respectively. The mean survival time of the 
A B
Fig. 1. An 85-year-old man with colon cancer. 
This patient complained of a palpable neck mass 23 months 
after an initial diagnosis with colon cancer. Ultrasonography 
(US) images (A, right transverse; B, left transverse) of the thyroid 
show diffuse enlargement with a heterogeneous appearance of 
the thyroid parenchyma. Several suspicious cervical lymph nodes 
(arrows) are noted on US (C). Final US assessment of this lesion 
was suspicious malignancy. US-guided fine-needle aspiration was 
performed from the right thyroid, revealing metastasis from colon 
cancer. Disseminated lung metastasis was also detected during the 
diagnostic work-up. The patient underwent systemic chemotherapy 
and died 2 months after detection of the thyroid metastasis.
CJung Hyun Yoon, et al.
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21 patients was 9.5 months, ranging from 2 to 38 months. The 
two patients who are alive have been treated with chemotherapy 
without surgery. 
US Features and US-FNA of Thyroid Metastases
The mean size of the metastatic lesions to the thyroid measured on 
US was 27.2 mm (range, 5 to 58 mm). The US appearance of the 23 
thyroid lesions were mass-forming in 21 (91.3%) and non-mass-
forming in 2 (8.7%) (Fig. 1). Seventeen of the metastatic lesions 
(73.9%) presented as single lesions, while the remaining 6 (26.1%) 
showed bilaterality. 
The US features of the 21 mass-forming metastatic lesions 
are summarized in Table 2. All 21 lesions showed solid tumor 
composition. Common US features among all 21 thyroid metastases 
were hypoechogenicity (81.0%); non-circumscribed margins, that 
is, microlobulated or irregular margins (90.5%); no calcifications 
(76.2%); and parallel shape (81.0%) (Fig. 2). Of the 14 nodules 
in which vascularity was available, 12 (85.7%) showed peripheral 
vascularity on power Doppler US. Regardless of the general US 
appearance of the 23 thyroid lesions, 21 (91.3%) were classified 
as suspicious malignancy,, and 2 (8.7%) as probably benign (Fig. 
3). Suspicious cervical lymph nodes were present in 18 patients 
(78.3%) (Figs. 1C, 2C). Three of the 21 suspicious malignant 
masses had more than 2 suspicious US features, among which 
hypoechogenicity, irregular margins, and the presence of suspicious 
cervical lymph nodes were present in all 3 cases. Of the 2 masses 
that were probably benign, 1 had suspicious cervical lymph nodes, 
while the other did not show abnormal cervical lymph nodes on US 
examinations. In the latter case, the thyroid nodule showed intense 
FDG uptake on PET scans which prompted us to perform US-FNA in 
spite of rather benign US features. 
Of the 23 lesions, 22 had US-FNA performed and 4 had US-CNB 
done with or without US-FNA. Among the 22 lesions with US-FNA, 
21 (95.5%) had diagnostic results specifically suggesting metastasis 
to the thyroid, and 1 (4.5%) was non-diagnostic. Two had US-CNB 
performed simultaneously with US-FNA according to the clinician’s 
request for special staining results needed in deciding upon a 
chemotherapy regimen, and 1 was performed after non-diagnostic 
cytology for confirmative results. 
Discussion
Clinically evident thyroid metastases are considered rather rare, 
mostly detected only on autopsy [15,21-24]. Technically, all sorts of 
primary tumors can metastasize to the thyroid, but tumors from the 
kidney, breast, and lungs were the most frequently reported sites, 
with clear cell renal cell carcinoma consisting of more than 50% of 
all thyroid metastases [4,6,25-28]. In our study though, the most 
common primary tumor site was the lung (37.5%, 9 of 24), followed 
by the colon and breast. Only 1 patient (4.2%) with renal cell 
carcinoma had metastasis in the thyroid gland, which is in conflict 
with many reports. This may have been due to the differences in 
cancer prevalence among study populations; newly developed 
malignancies involving the kidney comprise only 2.5% of all cancers, 
while cancers of the lung, gastrointestinal tract, and breast are 
leading causes of death in Korea [29]. 
US features of metastatic carcinoma to the thyroid are known to 
be nonspecific, appearing as inhomogeneous, hypoechoic, ill-defined, 
solid lesions with or without metastatic cervical lymphadenopathy 
[6,11,13,14,26]. The results of our study also revealed similar 
features; the most common US features in thyroid metastasis were 
Table 2. US features of the 21 mass-forming thyroid metastatic 
lesions
Variable No. of patients (%)
Composition
    Solid 21 (100.0)
    Mixed solid and cystic 0 (0.0)
    Cystic 0 (0.0)
Echogenicity
    Hyper- or isoechoic 0 (0.0)
    Hypoechoic 17 (81.0)
    Markedly hypoechoic 4 (19.0)
Margin
    Circumscribed 2 (9.5)
    Microlobulated 17 (81.0)
    Irregular 2 (9.5)
Calcifications
    Absent 16 (76.2)
    Present 5 (23.8)
Shape
    Parallel 17 (81.0)
    Non-parallel 4 (19.0)
Vascularity
    Peripheral 12 (85.7)
    Mixed 2 (14.3)
    Not available 7 (-)
Abnormal cervical lymph nodes
    Absent 3 (14.3)
    Present 18 (85.7)
Final assessment 
    Probably benign 2 (9.5)
    Suspicious malignancy  19 (90.5)Metastases to the thyroid gland
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solid composition, hypoechogenicity, non-circumscribed margins, 
no calcifications, parallel shape, and the presence of suspicious 
cervical lymph nodes. Most of the lesions included were assessed as 
suspicious malignancy (91.7%), which may lead to recommending 
US-FNA for diagnosis, but without acknowledgement of the 
patient’s cancer history, metastatic carcinoma of the thyroid may not 
be included in the differential diagnosis based on US features alone. 
Specifically, 17 of the metastatic lesions (73.9%) did not contain 
microcalcifications, a typical finding representing psammoma 
bodies in primary thyroid malignancy [30,31]. This, along with 
other suspicious US features, may lead to suspicion of metastasis in 
patients with a known primary tumor, as suggested in another study 
[14]. In addition, 78.3% of the patients included had suspicious 
cervical lymph nodes present on US examinations. Whereas US 
features of thyroid metastases prove to be rather nonspecific, the 
presence of suspicious lymph nodes in a patient who has been 
diagnosed or treated for cancer may raise suspicion of metastasis 
in thyroid masses revealed on the same US examination, especially 
among those showing no suspicious US features. For example, 1 of 
the 2 cases in our study showing US features that were probably 
benign had cervical lymph nodes suspicious for metastasis on US 
(Figs. 1, 2).
Several studies have suggested the preference of metastases to 
the thyroid in multinodular goiter or pre-existing thyroid nodules [16, 
26,29,32]. Metastasis to the thyroid is rather rare considering the 
vast blood volume passing through it, which can be explained by (1) 
the high oxygen and iodine concentration of the thyroid gland and 
(2) the rapid arterial blood flow passing through the thyroid gland 
[7,22,33]. It has been hypothesized that metastatic cells may favor 
thyroid parenchyma with preexisting thyroid abnormalities such as 
neoplasms, goiter, or thyroiditis, which contains lower concentrations 
of iodine or oxygen [16,29], but controversy remains. One report 
A B
Fig. 2. A 46-year-old man with stomach cancer. 
This patient presented with discomfort to the neck area 16 months 
after diagnosis with stomach cancer. Ultrasonography (US) was 
performed (A, transverse; B, longitudinal), revealing a 20-mm 
hypoechoic mass with irregular margins, parallel orientation, and no 
calcifications. Multiple suspicious cervical lymph nodes (arrows) can 
also be noted on the US (C). The final US assessment was suspicious 
malignancy. US-guided fine-needle aspiration was performed, and 
the thyroid mass was diagnosed as metastasis. Distant metastasis to 
the rectum had also been detected on endoscopic examination. The 
patient underwent systemic chemotherapy and died 19 months later.
CJung Hyun Yoon, et al.
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showed the development of metastasis within a preexisting thyroid 
nodule [16], but the detection of newly developed lesions within 
the thyroid is generally difficult without serial US examinations 
performed for comparison. Whether metastases to the thyroid glands 
actually prefer preexisting thyroid nodules was difficult to evaluate 
in this study because, in all of the 23 patients, the US examination 
revealing thyroid metastases was the initial examination performed.  
Early detection and treatment of metastases in cancer patients 
critically affect patient outcomes; therefore, differential diagnosis 
of thyroid lesions showing these US features is essential. When 
considering the grave prognosis of the patient if the lesion proves to 
be metastasis, preoperative diagnosis of the thyroid nodule can help 
avoid unnecessary surgery [4,6]. As in the differential diagnosis of 
various thyroid nodules besides metastatic carcinoma, US-FNA can 
be used as a simple, inexpensive, and effective tool in the cytologic 
diagnosis of metastatic lesions [3,6,12,19,28,32]. Of the 23 patients 
included in our study, 22 had undergone US-FNA for diagnosis, 
among which 21 (95.5%) had been specifically diagnosed with 
metastasis on cytology. Only 1 patient’s cytology turned out to be 
non-diagnostic, and this patient had thyroid metastasis confirmed 
by US-CNB. On cytologic evaluation, most cytology specimens from 
metastatic carcinoma to the thyroid show abundant cellularity with 
cells typical of the original cancer site [34]. However, even then, 
without being informed of the possibility of metastasis, diagnosis of 
metastatic lesions to the thyroid can be rather confusing since the 
cytology features of metastatic high-grade malignancy are similar 
to rare primary thyroid malignancies such as anaplastic or clear cell 
thyroid carcinoma [3,4,6,35]. Additional immunohistochemical stains 
may also aid the diagnosis of metastasis, showing negative results 
for thyroglobulin and calcitonin and positive results for cytokeratin 
subtypes [12,27]. Four patients included in this study had undergone 
immunohistochemical staining of cytology specimens, all of which 
showed negative results for thyroglobulin. In spite of the strengths 
of US-FNA in diagnosis of various thyroid lesions, controversy 
remains about using US-FNA on nodules suspicious for thyroid 
metastases, given its high false-negative rates, ranging from 13% 
A B
Fig. 3. A 62-year-old woman with lung cancer. 
On the 
18F-fluorodeoxyglucose positron emission tomography-
computed tomography scan obtained for lung cancer staging, an 
incidental thyroid mass with increased fluorodeoxyglucose uptake 
can be observed in the right thyroid (A). Ultrasonography (US) 
performed prior to US-guided fine-needle aspiration (US-FNA; B, 
transverse; C, longitudinal) shows a 24-mm hypoechoic solid mass 
with well-defined margins, parallel shape, and no calcifications. 
No suspicious cervical lymph nodes were detected on the US. The 
final US assessment of this lesion was probably benign. The result 
of US-FNA cytology was metastatic carcinoma from lung cancer. 
The patient underwent systemic chemotherapy and is alive to the 
present date, 60 months after diagnosis of the thyroid metastasis. 
CMetastases to the thyroid gland
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to 28.7% [33]. Surgical resection may be considered on selected 
patients for both diagnosis and complete resection of the metastatic 
mass, but whether surgery proves to be beneficial in patients with 
thyroid metastases has not yet been verified.
There are several limitations to our study. First, only one reviewer 
retrospectively reviewed the US features of the patients included 
in this study. The observations of additional reviewers may have 
produced different study results. Second, only 2 patients had been 
confirmed to have thyroid metastases based on surgical pathology. 
Although many studies have proven US-FNA to be accurate in the 
preoperative diagnosis of thyroid metastases, this method has its 
limitations in differential diagnosis between primary thyroid cancer 
such as anaplastic or clear cell variants and thyroid metastases [3,4, 
6,35]. 
In the present study, most of the thyroid metastases showed 
nonspecific US features such as hypoechogenicity, non-circumscribed 
margins, no calcifications, and parallel shape. Therefore, we 
recommend that US-FNA be performed when a hypoechoic thyroid 
nodule without malignant US features is sonographically detected in 
a patient with clinical suspicion of thyroid metastasis.
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